Baldry Mark (CIK 1644137) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-03). Recent activity: Buy XFOR (1,032 shares), Buy XFOR (1,032 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-03 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 1,032 | $2,559 |
| 2025-05-20 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 1,032 | $2,559 |
来源：SEC Form 4 申报文件 · 截至 2025-06-03